US Stock MarketDetailed Quotes

BLRX BioLine Rx

Watchlist
  • 0.540
  • +0.004+0.73%
Close Oct 1 16:00 ET
  • 0.540
  • 0.0000.00%
Post 18:20 ET
43.17MMarket Cap-1192P/E (TTM)

BioLine Rx Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

BioLine Rx Q2 2024 Earnings Date

Currency：USDAug 15, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
2.94M
5.39M
+2.45M
Beat Est.
--
--
+83.44%
EPS
-0.14
<0.01
+0.15
Beat Est.
+53.35%
+102.02%
+104.33%
Analyst Rating
Buy

Sep 30, 2024

BioLine Rx Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 4.738M--
--2024/Q3-- / 4.124M--
Aug 15, 20242024/Q25.393M / 2.940M--
May 28, 20242024/Q16.855M / 340.000K--
Mar 26, 20242023/Q44.800M / 165.000K--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 4.738M--
--2024/Q3-- / 4.124M--
Aug 15, 20242024/Q25.393M / 2.940M--
May 28, 20242024/Q16.855M / 340.000K--
Mar 26, 20242023/Q44.800M / 165.000K--

Unlock Free Earnings Estimates

BioLine Rx Earnings Reports

  • BioLine Rx | 6-K: Report of foreign private issuer (related to financial reporting)

    Aug 19 16:36 ET

  • BioLine Rx | 6-K: Report of foreign private issuer (related to financial reporting)

    Aug 15 07:12 ET

  • BioLine Rx | 6-K: Report of foreign private issuer (related to financial reporting)

    May 28 07:16 ET

  • BioLine Rx | 6-K: Report of foreign private issuer (related to financial reporting)

    Apr 1 10:36 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Sep 30, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data